British pharmaceutical giant AstraZeneca yesterday said net profit rose in its second quarter, driven once again by strong growth in sales of its cancer drugs.

British pharmaceutical giant AstraZeneca yesterday said net profit rose in its second quarter, driven once again by strong growth in sales of its cancer drugs.

It reported total revenues of 30.67 billion US dollars for the first six months of 2026.